Why Aminoglycosides Are Bactericidal While Other Protein Synthesis Inhibitors Are Bacteriostatic
Aminoglycosides are bactericidal because they irreversibly bind to the 30S ribosomal subunit, causing misreading of mRNA and producing defective proteins that incorporate into the bacterial cell membrane, leading to membrane permeabilization and cell death—a unique mechanism not shared by other protein synthesis inhibitors that reversibly bind to ribosomes. 1
Fundamental Mechanistic Differences
Aminoglycosides: Irreversible Binding and Membrane Disruption
- Aminoglycosides irreversibly bind to the 30S ribosomal subunit, causing misreading of mRNA and inhibition of protein synthesis 1
- This results in bactericidal activity even in non-dividing bacteria 1
- The misread proteins are defective and when incorporated into the cell membrane, they cause membrane permeabilization—this is the critical step that leads to bacterial death 2
- Aminoglycosides exhibit concentration-dependent killing, meaning higher concentrations kill bacteria more rapidly 3
- They possess a prolonged post-antibiotic effect (PAE) against gram-negative bacilli, continuing to suppress bacterial growth even after antibiotic levels fall below the minimum inhibitory concentration 3
Other Protein Synthesis Inhibitors: Reversible Binding
Tetracyclines:
- Reversibly bind to the 30S ribosomal subunit and prevent binding of t-RNA 4
- This reversible binding allows bacteria to resume protein synthesis once the drug is removed, resulting in bacteriostatic activity 4
Macrolides/Azalides:
- Bind to the 50S ribosomal subunit at the polypeptide exit region 4
- Are generally bacteriostatic, though they can be bactericidal against autolytic species such as pneumococci 4
- Recent evidence shows macrolides and tetracyclines can actually kill several commensal bacterial species, challenging the traditional bacteriostatic classification, but this species-specific killing is distinct from the broad bactericidal mechanism of aminoglycosides 5
Clindamycin:
- Binds to the 50S ribosomal subunit, interfering with translocation during elongation 1
- Is bacteriostatic and therefore not recommended for endovascular infections like infective endocarditis 6
- The FDA label confirms clindamycin is bacteriostatic 7
Chloramphenicol:
- Inhibits bacterial protein synthesis by interfering with transfer of activated amino acids from soluble RNA to ribosomes 8
- Exerts mainly a bacteriostatic effect on a wide range of gram-negative and gram-positive bacteria 8
Clinical Implications
The Bacteriostatic vs. Bactericidal Distinction in Practice
- The clinical relevance of bacteriostatic versus bactericidal activity is often overstated for most infections in immunocompetent patients 9
- Bacteriostatic agents have been effectively used for endocarditis, meningitis, and osteomyelitis—conditions traditionally thought to require bactericidal activity 9
- The ultimate guide to treatment must be clinical outcome, not just in vitro classification 9
Aminoglycoside Dosing Strategies
- Because of their concentration-dependent killing and prolonged PAE, aminoglycosides can be dosed less frequently than other antibiotics 3
- Once-daily dosing takes advantage of both the concentration-dependent killing mechanism and the post-antibiotic effect 3
- This dosing strategy has been applied to maximize efficacy and minimize toxicity 3
Common Pitfalls
- Do not assume all protein synthesis inhibitors work the same way—the reversible versus irreversible binding distinction is critical 1, 4
- Do not overlook that some "bacteriostatic" agents can be bactericidal against specific organisms (e.g., macrolides against pneumococci) 4
- Membrane permeabilization from defective proteins is unique to aminoglycosides—this is why other protein synthesis inhibitors don't cause the same bactericidal effect 2
- Recent research shows that aminoglycosides impose bacteriostatic effects mainly by inhibiting translocation, but become bactericidal in combination with decoding errors that produce aberrant proteins 10